The present invention provides a novel crystalline form of Betrixaban maleate, Betrixaban maleate Form APO-I, including Betrixaban maleate and dimethyl sulfoxide, compositions and processes for the preparation thereof, and the use of this crystalline form in the treatment of conditions characterized by undesired thrombosis, and in particular, venous thromboembolism (VTE).
展开▼